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In Brief
Using nuclear transfer to Xenopus
oocytes, Jullien et al. identify genes in
MEF nuclei whose epigenetic
configuration directly resists
transcriptional reprogramming by oocyte
factors. They show that loss of resistance
can be achieved by a combinatorial
action of chromatin modifiers, which alter
H2A ubiquitylation, H3K9, H3K27, and
DNA methylation levels.
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http://dx.doi.org/10.1016/j.molcel.2017.01.030SUMMARY
Understanding the mechanism of resistance of
genes to reactivation will help improve the success
of nuclear reprogramming. Using mouse embryonic
fibroblast nuclei with normal or reduced DNAmethyl-
ation in combination with chromatinmodifiers able to
erase H3K9me3, H3K27me3, and H2AK119ub1 from
transplanted nuclei, we reveal the basis for resis-
tance of genes to transcriptional reprogramming by
oocyte factors. A majority of genes is affected by
more than one type of treatment, suggesting that
resistance can require repression through multiple
epigenetic mechanisms. We classify resistant genes
according to their sensitivity to 11 chromatinmodifier
combinations, revealing the existence of synergistic
as well as adverse effects of chromatin modifiers
on removal of resistance. We further demonstrate
that the chromatin modifier USP21 reduces resis-
tance through its H2AK119 deubiquitylation activity.
Finally, we provide evidence that H2A ubiquitylation
also contributes to resistance to transcriptional re-
programming in mouse nuclear transfer embryos.
INTRODUCTION
Complete nuclear reprogramming is an inefficient process, irre-
spective of the procedure used (Gurdon, 1960; Pereira et al.,
2008; Takahashi and Yamanaka, 2006). The resistance to re-
programming is thought to come from the cellular mechanisms
that ensure the stability of the differentiated state. Understand-
ing how the differentiated state of a cell resists reprogrammingMolecular Cell 65, 873–884, M
This is an open access article undis key to our ability to improve the reprogramming procedure.
Importantly, disruption of cell identity can account for a large
part in the development of many diseases and in aging (Roy
and Hebrok, 2015; Sun et al., 2014). Therefore, analysis of resis-
tance to nuclear reprogramming provides a unique opportunity
to identify the stabilization mechanisms that are perturbed in
these situations.
Previous work has indicated that resistance to reprogramming
is partly linked to failure in gene activation. Numerous studies
have shown that the epigenetic configuration of somatic nuclei
can constitute a barrier to reprogramming (Cheloufi et al.,
2015; Mansour et al., 2012; Matoba et al., 2014; Mikkelsen
et al., 2008; Onder et al., 2012; Soufi et al., 2012). However,
because of the multiple cellular processes occurring at once
in reprogramming, a clear picture is lacking on (1) how directly
the epigenetic configuration of a gene will affect its reactivation
and (2) how multiple epigenetic marks regulate reactivation at
a single-gene level. We have recently described a nuclear trans-
fer procedure in whichmouse nuclei are transcriptionally reprog-
rammed toward an oocyte type of transcription (Jullien et al.,
2014). Importantly, this transcriptional reprogramming is directly
mediated by Xenopus oocyte factors and in the absence of
cell division. Here, using this direct assay, we first identify genes
that are resistant to transcriptional reprogramming. Increased
expression of these genes upon interference with the chromatin
status of transplanted nuclei reveals how resistance is achieved
on a single-gene basis. As a result, classes of resistant genes are
identified. At a single-gene level, we describe cases of neutral,
adverse, or synergistic effect of a combination of chromatin
modifier expression on transcription. We further demonstrate
that, in the case of USP21, the effect on resistance removal
can be attributed to the deubiquitylation of H2AK119 from trans-
planted chromatin. Finally, we provide evidence that resistance
to transcriptional reprogramming following nuclear transfer to
egg can also be alleviated by USP21 expression.arch 2, 2017 ª 2017 The Author(s). Published by Elsevier Inc. 873
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Identification of Genes Resisting
Transcriptional Reprogramming by Oocytes
(A) Schematic representation shows the nuclear
transplantation strategy used to identify genes resis-
tant to reactivation by Xenopus oocytes.
(B) MA plot shows log fold change (logFC, y axis) in
gene expression between MEF-NT versus ES-NT
against the expression in cultured MEFs (x axis, log2
reads per kilobase per million mapped reads [RPKM];
data from Reddington et al., 2013). Red and blue dots,
genes differentially expressed (FDR < 0.05, two ex-
periments, n = 32 NT samples per condition).
(C) Heatmap representing expression of the differen-
tially expressed genes (rows, Z score of normalized
expression level) between MEF-NT and ES-NT in ES
and MEF before and 48 hr after NT (columns, genes
sorted according to fold change between MEF-NT to
ES-NT). Expression data for cells before NT are from
Reddington et al. (2013) and Bulut-Karslioglu et al.
(2014).
(D) Boxplot shows the gene expression level before
and after NT of genes resistant in MEF-NT (538
genes, top) or resistant in ES-NT (424 genes, bottom).
+p value < 106, Wicoxon rank-sum test.
(E and F) The top (E) gene ontology terms and
(F) KEGG pathways enriched in the list of differentially
expressed (DE) genes restricted in MEF-NT and
ES-NT. See also Figure S1 and Tables S1 and S2.RESULTS
Identification of Genes Resistant to Transcriptional
Reprogramming
Mammalian nuclei transplanted to Xenopus oocyte are reprog-
rammed from a somatic to an oocyte type of transcription (Jullien
et al., 2014). In the context of such a genome-wide change in
transcription, the proportion of genes that resist the reprogram-
ming activity of the oocyte is unknown. To identify such genes,
we have compared the reprogramming of mouse embryonic
stem cell nuclei to that of fibroblast nuclei transplanted to oo-
cytes (Figure 1A). In this experimental setup, we can compare
the transcription from two types of transplanted chromatin
exposed to the same oocyte factors. To label RNAs produced af-
ter transplantation, we injected BrUTP to the oocyte 2 hr after nu-
clear transfer (Jullien et al., 2014). At 48 hr after nuclear transfer,874 Molecular Cell 65, 873–884, March 2, 2017labeled RNAs were immunopurified and
subjected to RNA sequencing (RNA-seq)
analysis. Such procedure excludes somatic
cell transcripts carried over during nuclear
transplantation, and, therefore, it focuses
our analysis exclusively on oocyte factor-
mediated transcription. Hierarchical clus-
tering of gene expression confirmed that
the BrUTP injection allowed the purification
of labeled RNAs, as the samples injected
with BrUTP clustered away from the
control samples generated without BrUTP
(Figure S1A).
Transplanted embryonic stem cell (ESC)
nuclei share a large number of transcribedgenes with fibroblasts (gray dots, 13,827 genes; Figure 1B; Table
S1). This indicates that the oocyte has an efficient reprogram-
ming activity, since nuclei originating from cells as different as
an embryonic stem cell and an embryonic fibroblast express a
large number of genes after nuclear transfer (of all genes ex-
pressed after nuclear transfer, 93% are similarly expressed be-
tween ESC and mouse embryonic fibroblast (MEF) nuclei, as
compared to 52% before transplantation). However, we found
that a number of genes are differentially expressed (false discov-
ery rate [FDR] < 0.05) between transplanted ESC andMEF nuclei
(Figure 1B, blue and red dots; Table S1). The qRT-PCR analysis
confirmed differential expression of 15/17 genes tested, indi-
cating the robustness of our RNA-seq assay (Figure S1B).
The oocyte better transcribes these genes from one type of
transplanted nucleus than from the other. This suggests that dif-
ferences in the epigenetic constitution between these two types
−4 −2 TSS 2 4
0
10
00
20
00
30
00
40
00
DNaseI
D
N
A
se
 (p
er
 bi
llio
n r
ea
ds
, 
pe
r g
en
e)
OOC−resistant Reprogrammed Maintained
−
40
−
20
0
20
40
60
80 H3K27me3
−4 −2 TSS 2 4
−
80
−
60
−
40
−
20
0
H3K9me3
−4 −2 TSS 2 4
0
50
0
15
00
25
00
35
00
H3K4me3
−4 −2 TSS 2 4
0
50
10
0 H2AK119ub1
−4 −2 TSS 2 4
−
40
−
20
0
H3K9me3
−4 −2 TSS 2 4
Synkaryon−resistant
(Looney et al,2014)
OOC−resistant Egg−resistant
(Matoba et al,2014)
iPS−resistant
(Soufi et al,2012)
0
50
0
10
00
15
00
20
00 DNaseI
−4 −2 TSS 2 4
0
50
10
0
15
0
20
0 H3K27me3
−4 −2 TSS 2 4
0
50
10
0
15
0
20
0 H2AK119ub1
−4 −2 TSS 2 4
0
50
0
10
00
15
00 H3K4me3
−4 −2 TSS 2 4
0
4
8
12
16
oo
cy
te
sy
nk
ary
on eg
g
iPS
DNAme
0
4
8
12
16
%
 D
N
A
 m
et
hy
la
tio
n 
at
 C
pG
3k
B
 u
ps
tre
am
 o
f T
SS
Ma
int
ain
ed
Re
pro
gra
mm
ed
re
sis
tan
t
DNAme
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
D
N
A
se
 (p
er
 bi
llio
n r
ea
ds
, 
pe
r g
en
e)
%
 D
N
A
 m
et
hy
la
tio
n 
at
 C
pG
3k
B
 u
ps
tre
am
 o
f T
SS
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
IP
 −
 In
pu
t (
pe
r b
illi
on
 re
ad
s,
 
pe
r g
en
e)
A
B
G
H J L
I K
D F
C E
Figure 2. Epigenetic Configuration of MEF Genes Resistant to OOC-Mediated Transcriptional Reprogramming
(A–E) Shown is the (A) DNase I sensitivity (Yue et al., 2014), (B) H3K4me3 (Kaneda et al., 2011), (C) H3K27me3 (Kaneda et al., 2011), (D) H2Aub (this study), and (E)
H3K9me3 (Bulut-Karslioglu et al., 2014) metaplot analysis ±5 kB around the TSSs, in MEF, of genes with reprogrammed (green), maintained (blue), and resistant
(red) expression following nuclear transfer.
(legend continued on next page)
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of nuclei is such that some genes are resistant to the oocyte re-
programming factors in one but not the other type of nucleus.
These genes are referred to as resistant genes. There were
fewer genes resistant to reprogramming in transplanted ESCs
compared with transplanted MEFs (538 versus 424, Figure 1B),
presumably reflecting the more permissive chromatin organiza-
tion of the pluripotent cell (Meshorer et al., 2006). A heatmap
showing relative expression of resistant genes before and after
nuclear transfer shows that resistance is associated with lower
expression in the corresponding donor cells prior to transplanta-
tion (Figures 1C and 1D). This suggests that resistance originates
from epigenetic mechanisms established in the somatic cell to
ensure stable gene silencing, safeguarding cell identity. In agree-
ment with this idea, gene ontology analysis of resistant genes in-
dicates enrichment for functions related to transcription, devel-
opment, and germ cell and reproduction (Figure 1E; Table S2).
These functional categories may reflect the oocyte’s transcrip-
tional activity toward an accumulation of factors necessary for
the development of the oocyte and of the future embryo. Addi-
tionally, the Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways enriched among resistant genes include can-
cer and tight junction in MEFs and cell signaling in ESCs (Fig-
ure 1F; Table S2). This suggests that the genes related to these
functions are under a particularly strong repressive regime in the
corresponding donor cell, leading to resistance to the reprog-
ramming activity of the oocyte.
We conclude that, inmouse fibroblasts, a set of 538 genes, en-
riched for geneswith early embryo/germ cell-related functions, is
resistant to the reprogramming activity of the oocyte.
Epigenetic Features of Resistant Genes
To understand how resistance is achieved, we first investigated
what type of epigenetic features characterize the chromatin
at the transcription start sites (TSSs) of resistant genes in the
donor MEFs. We first compared resistant genes to genes whose
expressionwepreviously identified asmaintainedor successfully
reprogrammed in MEF nuclei transplanted to oocytes (Jullien
et al., 2014). As expected, on average, resistant genes exhibited
a closed chromatin configuration when compared to maintained
and reprogrammed genes, as shown by DNaseI sequencing
(DNaseI-seq) (Yue et al., 2014) (Figure 2A). Resistant genes also
were associated with low levels of H3K4me3, a histonemodifica-
tion associated with active transcription (Kaneda et al., 2011)
(Figure 2B). By contrast, repressive marks H3K9me3 (Bulut-Kar-
slioglu et al., 2014), H3K27me3 (Kaneda et al., 2011), and
H2AK119ub1 all exhibited higher levels around the TSSs of resis-
tant genes than around maintained or reprogrammed genes
(Figures 2C–2E). Lastly, we observed that restricted genes ex-
hibited a higher level of methylated CpG than maintained or re-
programmed genes (Figure 2F; Figure S2). These observations(F) DNA methylation in the promoter region (3 kb upstream TSS) of reprogra
showing >95% methylation (data from Reddington et al., 2013).
(G–K) Shown is the (G) DNase I sensitivity (Yue et al., 2014), (H) H3K4me3 (Kaneda
H3K9me3 (Bulut-Karslioglu et al., 2014) metaplot analysis ±5 kB around the TSSs
(orange, from Matoba et al., 2014), transcription factor-induced reprogramming (
(L) DNAmethylation in the promoter region (3 kb upstream TSS) of genes resistant
cell fusion is shown as the percentage of CpG showing >95% methylation (data
876 Molecular Cell 65, 873–884, March 2, 2017confirm that resistant genes have, as a whole, a different epige-
netic configuration than genes that are readily reprogrammed
or continuously expressed after nuclear transfer.
We further characterized the resistant gene state by asking
whether resistance, as shown in the Xenopus oocyte nuclear
transfer assay, bears any similarity, at the epigenetic level, with
genes showing transcriptional resistance in other reprogram-
ming assays. We compared the set of oocyte reprogramming-
resistant genes identified here (Ooc resistant) to genes identified
as resistant to reprogramming following transplantation to the
mouse egg (egg resistant; Matoba et al., 2014), transcription fac-
tor-induced pluripotency (iPS resistant; Soufi et al., 2012), or cell
fusion (Synkaryon resistant; Looney et al., 2014). Metaplot anal-
ysis indicates that, similar to Ooc-resistant genes, genes resis-
tant to reprogramming in iPS, egg-NT, and cell fusion also
showed reduced chromatin accessibility and enrichment for
repressive histone marks when compared to successfully re-
programmed genes (Figures 2G–2L). This suggests that the
epigenetic mechanisms conferring resistance to reprogramming
are similar in these reprogramming systems.
In conclusion, we found that the Ooc-resistant genes have an
epigenetic makeup that is similar to that of genes resistant to re-
programming in other systems and that distinguishes them from
successfully reprogrammed genes. We next sought to investi-
gate whether these epigenetic marks mediate resistance to tran-
scriptional reprogramming.
Overexpression of Chromatin Modifiers Alleviates
Resistance
To alter the chromatin of transplanted nuclei, we pre-injected oo-
cytes with mRNAs encoding chromatin modifiers either alone or
in combination (Figure 3A). Based on the chromatin features of
resistant genes described above, we used chromatin modifiers
targeting histone modifications involved in transcriptional
repression: Kdm4d (H3K9 demethylase; Shin and Janknecht,
2007), Kdm6b (H3K27 demethylase; Agger et al., 2007), and
USP21 (H2AK119 deubiquitylase; Nakagawa et al., 2008). We
also used a combination of USP21 and Kdm6b in order to erase
repressive histone marks associated with polycomb repressive
complexes 1 and 2, respectively. Lastly, we combined the
removal of polycomb complex repressive marks with that of
H3K9 methylation (co-expression of USP21, Kdm6b, and
Kdm4d). Then 24 hr after mRNA injection, nuclei were trans-
planted to the oocytes, and, another 48 hr after nuclear transfer,
the transplanted nuclei were recovered and analyzed by western
blot analysis. The overexpression of chromatin modifiers led to
an efficient removal of histone modifications from the trans-
planted nuclei (Figure 3B; Figure S3).
Using this chromatin modification strategy, we transplanted
nuclei from wild-type (WT) or DNA methylation-deficientmmed, maintained, or resistant genes is shown as the percentage of CpG
et al., 2011), (I) H3K27me3 (Kaneda et al., 2011), (J) H2Aub (this study), and (K)
of genes showing resistance in OOC-NT (red, from this study), mouse egg-NT
purple, from Soufi et al., 2012), and cell fusion (gray, from Looney et al., 2014).
in OOC-NT, mouse egg-NT, transcription factor-induced reprogramming, and
from Reddington et al., 2013). See also Figure S2.
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Figure 3. Chromatin Modifier Overexpres-
sion Alleviates Resistance to Transcrip-
tional Reprogramming
(A) Schematic representation shows the nuclear
transplantation strategy used to test the sensitivity
of resistant genes to chromatin modifiers.
(B) Western blot analysis of modified histones on
chromatin recovered 48 hr after nuclear trans-
plantation to oocyte expressing single or multiple
chromatin modifiers is shown.
(C) Summary shows the 12 chromatin con-
figurations tested in the OOC transcriptional re-
programming assay.
(D) Boxplot shows the log fold change between
resistant gene expression in MEF-NT in various
chromatin configurations to that of ES-NT.
(E) Number of resistant genes as judged by
differential gene expression analysis between
RNA-seq data from ES-NT and MEF-NT in various
chromatin configurations (FDR < 0.05, two ex-
periments, n = 32 NT samples per conditions). See
also Figure S3 and Table S3.fibroblasts (Dnmt1N MEF; Jackson-Grusby et al., 2001; Lande-
Diner et al., 2007) to oocytes expressing chromatin modifiers,
and we analyzed transcriptional reprogramming by RNA-seq.
This allowed us to determine the expression of resistant genes
from two types of transplanted chromatin (with or without DNA
methylation) in six different histone modification configurations
(Figure 3C). We observed that chromatin modifier expression
increased the average expression level of resistant genes, in
agreement with the role of the targeted histone modifications
in gene repression (Figure 3D). The observed increase in expres-
sion was associated with a loss of resistance in a large propor-
tion of resistant genes for any given treatment, as judged by
the loss of differential expression between ESCs and treated
MEFs 48 hr after nuclear transfer (Figure 3E; Table S3). Of all sin-Molegle treatments, Kdm4d was the most
effective and the loss of DNA methylation
was the least effective (Figure 3E, 166
and 328 resistant genes left, respec-
tively). The greatest effect was found
with the combination of Kdm4d, Kdm6b,
and USP21 on chromatin with normal
DNA methylation (Figure 3E). Interest-
ingly, in the context of DNA hypomethyla-
tion, the expression of chromatin modi-
fiers had a less pronounced effect.
We conclude that overexpression of
chromatin modifiers generally decreases
the resistance to transcriptional reprog-
ramming both in the presence and
absence of DNA methylation.
A Unique Pattern of Resistant Gene
Sensitivity to Chromatin Modifier
Treatment
Each chromatin modifier treatment was
affecting the expression of a large frac-tion of resistant genes (Figure 3E). This suggests that, at a sin-
gle-gene level, resistance can be alleviated by more than one
type of treatment. To investigate the sensitivity of resistance to
multiple treatments, we focused first on the effect of single chro-
matin modifier treatment, and we evaluated how often overex-
pression of Kdm4d, Kdm6b, and USP21 as well as inactivation
of Dnmt1 could affect the expression of the same resistant genes
(Figure 4A). First, we observed that only 93 resistant genes were
not affected by any of these four treatments. The remaining
genes (445/538) lost resistance in at least one of the treatments,
and the majority was affected by more than one treatment. Inter-
estingly, a very large number of resistant genes (123) were upre-
gulated in all four individual treatments. Altogether, these obser-
vations suggest that, at a single-gene level, multiple silencingcular Cell 65, 873–884, March 2, 2017 877
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Figure 4. Multiple ChromatinModifier Com-
binations Affect Resistance at a Single-
Gene Level
(A) Venn diagram shows the number of genes
losing resistance upon four individual chromatin
modifier treatments.
(B) Example of digital signature of resistance
obtained by differential gene expression analysis
for a non-resistant (G3pdh) and three resistant
(Trap1A, Otx2, and Sox2) genes. The digital
signature indicates whether a gene is resistant
(shown as 1 when the gene is differentially ex-
pressed in MEF-NT compared to ES-NT) or loses
resistance (shown as 0, when the gene is not
differentially expressed in MEF-NT compared
to ES-NT) in each of the 12 conditions tested. The
bar graphs show qRT-PCR analysis of gene
expression (mean ± SEM of four samples of eight
oocytes NT).
(C) The numbers of genes for which a synergistic,
neutral, adverse, or insensitive effect is observed
when combining two chromatin modifier treat-
ments are shown.
(D) Venn diagram shows the number of genes
sensitive to a histone modifier (Kdm4d, Kdm6b, or
USP21) in nuclei with normal (WT) or hypomethy-
lated DNA (Dnmt1N).
(E) Loss of resistant gene sensitivity to Kdm6b in
DNA-hypomethylated MEF correlates with loss of
H3K27me3. The y axis indicates the number of
genes that lose H3K27me3 in MEF with hypo-
methylated DNA compared to WT MEF. Resistant
genes are split according to change in sensitivity
to Kdm6b after NT when comparing WT MEF to
MEF with hypomethylated DNA (red dot). The
boxplot shows the background distribution of
H3K27me3 change when sampling 10,000 times
for a random set of genes of the same size as
the resistant gene subset tested. The number in
parentheses indicates a p value generated by
calculating the proportion of the random back-
ground that has a more extreme value than the
observed percentages from each of the three
groups.
(F) Heatmap illustrating the change in gene
expression in normal (WT MEF nuclei) or hypo-
methylated DNA (Dnmt1N MEF nuclei) upon
expression of histone modifiers. Ten clusters
representing the main trend of gene expression
change were selected based on k-means clus-
tering of expression data from RNA-seq analysis
(RPKM). The trend of change in gene expression
in these ten clusters is shown in the heatmap as a
Z score. See also Table S4.mechanisms contribute resistance to transcriptional reprogram-
ming by the oocyte factors.
To investigate further the relationship between resistance and
chromatin modifiers at a single-gene level, we classified resis-
tant genes according to their resistance to transcriptional re-
programming in all 12 conditions tested (listed in Figure 3C).
For each resistant gene, differential expression analysis at
48 hr after nuclear transfer between ESC nuclei and MEF nuclei
was used to determine whether this gene maintained or lost
resistance in the various treatment used. This can be repre-878 Molecular Cell 65, 873–884, March 2, 2017sented as a digital signature of resistance. When a gene was
still differentially expressed upon a given treatment in MEF-NT
compared to ES-NT (LogFC [MEF/ES] < 0 and FDR < 0.05), it
was assigned a value of 1, indicating that resistance was main-
tained in that condition. If by contrast there was no differential
expression of the gene between treated MEF-NT and ES-NT, it
was assigned a value of 0, indicating that resistance was lost
in that condition. An example of this signature is shown for three
resistant genes, Trap1a, Sox2, and Otx2, and for one non-resis-
tant gene, G3pdh (Figure 4B). When analyzed by qRT-PCR, an
increase in gene expression was detected for all treatments
where differential gene expression analysis also identified a
loss of resistance. For all 538 resistant genes, such a digital
signature was generated (Table S4). This analysis showed that
the epigenetic features tested here account for a significant
part of the resistance to transcriptional reprogramming by the
oocytes, as only 47 genes (8.7% of all resistant genes) remained
resistant when considering all conditions tested. We identified a
very large number of digital signature types (232 for 538 genes),
indicating that the pattern of sensitivity to chromatin modifier
treatment is almost unique to each resistant gene.
Synergistic, Neutral, and Adverse Effects of a
Combination of Chromatin Modifiers
We next sought to investigate the effect of combining chromatin
modifier treatments on loss of resistance. We compared the use
of two simultaneous treatments versus single treatments. The
effects seen fell into one of three classes.
First, we observed a neutral effect, when the combined treat-
ments led to the same effect on resistance as the single treat-
ments. This took place when loss of resistance was seen at least
in one of the single treatments, and this loss was still seen when
combining the treatments (neutral, Figure 4C). We also found in-
stanceswhere the gene remained resistant in both the single and
combined treatments (insensitive, Figure 4C). This lack of addi-
tional effect of combining chromatin modifiers was by far the
most common (neutral and insensitive accounted for >70% of
resistant genes in all combinations tested).
Additionally, we observed cases of synergistic effects when
loss of resistance was only seen in the double treatments. This
effect was not so common when combining loss of DNA
methylation to histone modifier. However, USP21 and Kdm6b
synergistically removed resistance from about 10% of resistant
genes (54/538). This suggests that the repressive histone marks
targeted by these enzymes (H2AK119ub1 andH3K27me3, asso-
ciated with polycomb repressive complexes 1 and 2 [PRC1
and PRC2], respectively) independently ensured repression of
these genes.
Surprisingly, we observed numerous instances of adverse ef-
fect, when a gene lost resistance in at least one individual treat-
ment but remained resistant when the treatments were com-
bined (Figure 4C). This happened particularly when a gene lost
resistance upon histone modifier treatment only in the context
of normal DNA methylation, but not in the context of chromatin
with reduced DNA methylation (Figure 4D). This adverse effect
of DNA methylation loss on resistance sensitivity to chromatin
modifier suggests that inactivation of Dnmt1 in the cultured cell
induces changes in the distribution of repressive histone modifi-
cation around resistant genes in the donor nuclei.
To investigate this possibility, we analyzed the relationship
between the distribution of H3K27me3 in WT and DNA hypome-
thylated cells and the sensitivity of resistant genes to the H3K27
demethylase Kdm6b following nuclear transfer. Previous studies
have shown significant changes in the distribution of H3K27me3
upon loss of DNA methylation (Reddington et al., 2013).
Decrease in DNA methylation level leads mostly to a spreading
of H3K27me3 to a larger part of the genome without an overall
increase in H3K27me3 in the cell, resulting in H3K27me3 lossfrom numerous genomic locations. We observed that loss of
H3K27me3 upon reduction of DNA methylation was more pro-
nounced on resistant genes that lost sensitivity rather thanmain-
tained sensitivity to Kdm6b, when comparing the reprogram-
ming of DNA hypomethylated nuclei to that of WT nuclei
(Figure 4E). This suggests that loss of Kdm6b sensitivity in hypo-
methylated DNA nuclei is indeed mediated by a redistribution of
H3K27me3 in the donor nuclei.
Digital signature analysis identified genes that show the same
pattern of loss of resistance across multiple treatments (Table
S4). However, the change in gene expression that underlies this
loss of resistance could vary greatly between treatments and is
not reflected in this categorization. For example, the loss of resis-
tance for Otx2 in the presence of Kdm4d and Kdm6b corre-
sponded to an increase in gene expression over control condi-
tions of 4- and 15-fold, respectively, as judged by qRT-PCR
analysis (Figure 4B). To take into account more subtle changes
in gene expression underlying loss of resistance, we clustered
resistant gene expression levels across all treatments (Figure 4F).
We reduced the number of patterns of resistance sensitivity to
treatments from the initial 232 types identified by digital signature
analysis (Table S4) to ten main groups (Figure 4F). When taking
into account the scale of thechange ingene expression,wecould
further reduce the complexity of pattern observed by grouping
resistant genes according to their trendof expression in response
to chromatinmodifier treatments. This analysis indicated that the
effect of a combination of chromatin modifiers on resistance is
rarely neutral and that synergistic/additive and adverse effects
are much more common.
Loss of Resistance upon Usp21 Expression Correlates
with Enrichment for H2Aub on the Affected Genes
Given that, at a single-gene level, resistance often can be
removed by the expression of more than one type of chromatin
modifier, this raises the question of the mechanism of action of
these factors (Figure 4A). Indeed, although the reprogramming
system described here is independent of replication and is
directly mediated by oocyte factors, it does not exclude the pos-
sibility that the chromatin modifiers act on transcription indepen-
dently of their activity against their cognate chromatin targets. In
fact, targets besides the classical histones, such as transcription
factors, have been found to be affected by chromatin modifiers
(Carr et al., 2015).
To investigate if chromatin modifiers affect resistance through
the removal of repressive marks from chromatin, we first
analyzed whether loss of resistance after expression of a given
chromatin modifier correlates with the presence of its target
epigenetic mark on the resistant genes. Because its chromatin
modifier activity is less well characterized than that of Kdm4d
and Kdm6b, we focused on the characterization of USP21
effect on resistance. We first investigated the distribution of
H2AK119ub1 by chromatin immunoprecipitation sequencing
(ChIP-seq). H2AK119ub1 was more abundant around the TSSs
of genes that were not expressed rather than expressed in
cultured MEFs, in accordance with the repressive function of
this histone modification (Zhou et al., 2008) (Figure 5A).
When focusing on resistant genes, we observed a relative
H2AK119ub1 enrichment on USP21-sensitive genes comparedMolecular Cell 65, 873–884, March 2, 2017 879
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Figure 5. USP21 Removes Resistance through
Deubiquitylation of H2A
(A) Metaplot analysis in MEF of H2AUb ChIP-seq ±5 kb
around the TSSs of genes expressed (green) or not
expressed (blue) in MEF is shown.
(B) Same as (A) but resistant genes are split according
to sensitivity (red line) or insensitivity (red dashed line)
to USP21.
(C) WB analysis of H2AK119ub1 level in WT or
Ring1a&b KO-transplanted nuclei 0 and 48 hr after
nuclear transfer. Nuclei were transplanted in control
oocyte or in oocyte overexpressing USP21 or catalyt-
ically inactive XlRing1b (Ring Mut).
(D) Boxplot shows expression of the set of genes up-
regulated in WT MEF transplanted to USP21
compared to WT MEF transplanted to control oocytes
(+p value < 1011, Welch two-sample t test).
(E) Heatmap showing unsupervised hierarchical clus-
tering of genes upregulated inWTMEF transplanted to
USP21-expressing oocyte compared to control oo-
cytes in WT MEF transplanted to control oocytes, to
USP21-expressing oocytes, to XlRing1b mutant-ex-
pressing oocytes, and in Ring1a&Ring1b KO MEF
transplanted to control oocytes. Expression value is
shown as log2(1 + RPKM).
(F) dCas9-USP21 targeted to the Otx2 promoter de-
creases Otx2 resistance to transcriptional reprogram-
ming. The qRT-PCR analysis of Otx2 and Sox2 gene
expression 48 hr after MEF transplantation to oocytes
injected with water (control), USP21 RNA, or USP21-
dCas9 RNA, with or withoutOtx2 gRNAs mix, is shown
(+p value < 0.05, Student’s t test; mean ± SEM of four
experiments). See also Figure S4 and Table S5.to USP21-insensitive genes in donor nuclei (Figure 5B). The fact
that high levels of H2Aub were present on USP21-sensitive
genes was consistent with the idea that USP21 suppresses
resistance through deubiquitylation of H2AK119 on this set of
gene. We next sought to test this mechanism by complementary
approaches.
USP21 Removes Resistance through the Removal of
H2A Ubiquitylation
We first reduced the level of H2AK119ub1 on transplanted chro-
matin after nuclear transfer. This was achieved either by overex-
pressing the deubiquitylase USP21, as described above, or by
overexpressing a catalytically inactive form of XlRing1b, the E3
ligase responsible for H2A ubiquitylation by the PRC1 complex
(de Napoles et al., 2004). Similar to USP21 overexpression,880 Molecular Cell 65, 873–884, March 2, 2017Ring1B mutant overexpression reduced the
level of H2AK119ub1 on transplanted chro-
matin 48 hr after transplantation (Figure 5C).
Second, we reduced H2AK119ub1 level in
thedonor nucleiprior to nuclear transfer using
Ring1a&Ring1b knockout (KO) MEF (Endoh
et al., 2012). In that case, the transplanted
nuclei were initially devoid of H2AK119ub1.
However, 48 hr after nuclear transfer, they re-
gained levels of H2AK119ub1 similar to those
of WT nuclei (Figure 5C).We then used RNA-seq analysis to investigate the effect of
these three treatments on gene expression following nuclear
transfer. USP21 overexpression, XlRing1B mutant overexpres-
sion, and transplantation of Ring1a/b KO nuclei resulted in an
increased expression over control nuclear transfer of 165, 73,
and 79 genes, respectively (Table S5). We first noted a correla-
tion between the extent of H2AK119ub1 level decrease and
the number of upregulated genes, suggesting that the effect
observed on gene expression was indeed dictated by the effect
of the treatments on H2AK119ub1 level. Importantly, the genes
upregulated in conditions where Ring1a/b KO nuclei were trans-
planted or XlRing1b mutant was overexpressed were signifi-
cantly enriched for the genes that also were upregulated by
USP21 overexpression (22/79 and 13/73, respectively; p value <
1010, hypergeometric test). Although statistically significant, the
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Figure 6. USP21 Improves Transcriptional
Reprogramming of Two-Cell-Stage Cloned
Mouse Embryos
(A) MA plot showing log fold change in gene
expression between fertilized embryos and ES clone
embryos (logFC, y axis) against the log of gene
expression in cultured ES (logCPM, x axis). Differ-
entially expressed genes are shown in red and
blue for genes downregulated and upregulated in
clones compared to fertilized embryos, respectively
(FDR < 0.05, three experiments).
(B) Same as (A) except that USP21 was overex-
pressed in the cloned embryos.
(C and D) Venn diagram indicating the overlap be-
tween the downregulated genes (C) and upregulated
genes (D) in control and USP21 clones. See also
Figure S5 and Tables S6 and S7.overlap between these gene sets is relatively small, presumably
because of the differential effect of the corresponding treatment
on H2AK119ub1 level during the course of the experiment (see
above). Additionally, the genes that were upregulated in MEF
nuclei transplanted to USP21-expressing oocytes compared to
control oocytes also showed significantly higher expression in
transplanted Ring1a&b KO nuclei or in WT nuclei transplanted
to oocytes overexpressing XlRing1b mutant (Figure 5D). Lastly,
the genes that were upregulated upon USP21 overexpression
showed a similar pattern of upregulation in the two other treat-
ments reducing H2AK119ub1 level (Figure 5E).
We observed that three ways of interfering with H2AK119ub1
led to the upregulation of a similar set of genes in transplanted
nuclei. We conclude that USP21 overexpression removes resis-
tance mostly through its H2A deubiquitylation activity.
To further test whether USP21 acts through chromatin deubi-
quitylation of H2A, we targeted USP21 to one resistant gene
rather than the whole nuclear chromatin. We fused USP21 to
dCas9 in order to direct USP21 to the promoter region of the
resistant gene Otx2 using small guide RNAs (sgRNAs) (Fig-
ure S4). We found a significant loss of Otx2 resistance to tran-
scriptional reprogramming following nuclear transfer to oocytes
expressing USP21dCas9 and guide RNAs targeting the Otx2
promoter, but not in the absence of guide RNAs (Figure 5F).
This correlates with a guide RNA-dependent deubiquitylation
of H2A at the Otx2 promoter (Figure S4C). Importantly, in the
conditions used, global levels of H2Aub were not decreased,
as shown by western blot (WB) (Figure S4A) and ChIP-qPCR
on repeat elements of the genome (major satellites and intracis-
ternal A particles [IAPs], Figure S4C). We conclude that a local-
ized decrease in H2Aub at the promoter is sufficient to reduce
resistance following nuclear transfer.MoUSP21 Improves Transcriptional
Reprogramming of Cloned Mouse
Two-Cell Embryos
We next asked whether USP21 also could
alleviate resistance to transcriptional re-
programming after mouse nuclear transfer
to enucleated MII oocytes. We performed
cloning experiments in the mouse, in whichmouse ESC (mESC) nuclei were transplanted to enucleated
eggs. We let such reconstituted embryos develop to the two-
cell stage, when zygotic gene activation occurs, and we
analyzed gene expression by RNA-seq (Figure 6A). As a control,
we used two-cell-stage embryos obtained by in vitro fertilization.
We identified 1,332 genes misregulated in cloned embryos
compared to fertilized embryos (577 downregulated genes and
755 upregulated genes, FDR < 0.05 and jlogFCj > 1; Table S6),
a number similar to what has been described in two-cell-stage
embryos cloned from mouse fibroblast nuclei (Matoba et al.,
2014). We then asked whether the gene misregulation observed
in the cloned embryos could be reduced by USP21 treatment. To
that end, cloned embryos were reconstructed by transplanting
ESC nuclei to enucleated egg pre-injected with USP21mRNA in-
jection. At the two-cell stage, the chromatin of these embryos
exhibited a reproducible reduction of H2AK119ub1 level (Fig-
ure S5). RNA-seq analysis indicated 293 downregulated genes
and 490 upregulated genes in USP21 clones compared to
in vitro fertilization (IVF) embryos (Figure 6B). This corresponds
to a reduction in the number of downregulated and upregulated
genes between USP21 clones and control clones of 50% and
35%, respectively (Figures 6C and 6D).
We conclude that resistance to transcriptional reprogramming
at zygotic gene activation in cloned mouse embryos also can be
reduced by the expression of USP21.
DISCUSSION
Interference with several epigenetic pathways, such as those
involving repressive methylation of histones (Soufi et al., 2012;
Onder et al., 2012), DNA methylation (Mikkelsen et al., 2008),
or histone deposition (Cheloufi et al., 2015; Gaspar-Maia et al.,lecular Cell 65, 873–884, March 2, 2017 881
2013; Pasque et al., 2012), all can lead to an improvement in iPS
reprogramming efficiency. In these experiments, however, it is
not clear whether the increase in efficiency is mechanistically
linked to a direct effect of chromatin modifiers on the transcrip-
tion of genes resistant to reprogramming. Additionally, it is not
known whether different ways of improving reprogramming
through chromatin-based interference act on similar or indepen-
dent pathways, as they have not been systematically combined,
presumably because of the detrimental effect of doing so on
cell viability. Indeed, interference with chromatin chaperones
together with histone methylase or components of PRC1 and
PRC2 have been reported to have adverse effects in iPS exper-
iments, precluding the analysis of treatment combinations (Che-
loufi et al., 2015; Onder et al., 2012).
Our oocyte-reprogramming assay allowed us to circumvent
this problemandmeasure thedirect effect of removing chromatin
repressivemarks, alone or in combination, on gene transcription.
Strikingly, challenging the stability of the repressed state through
nuclear transfer reveals that many of the resistant genes are
directly sensitive to interference with more than one epigenetic
repressive pathway. This observation suggests that the stabiliza-
tion of gene expression pattern involves the establishment of
multiple layers of epigenetic repression on a subset of genes crit-
ical for safeguarding the identity of a cell. This is in agreementwith
mechanisms described for gene silencing during cell differentia-
tion. For example, silencing of the pluripotency gene Oct4 during
stem cell differentiation entails the deacetylation of histone fol-
lowed by the methylation of H3K9 and, eventually, DNA methyl-
ation (Epsztejn-Litman et al., 2008; Feldman et al., 2006). Simi-
larly, the inactivation of X chromosome in female cells during
early embryogenesis in the mouse involves the concerted action
ofmultiple repressive pathways, including long noncodingRNAs,
H3K27methylation, histone variant deposition, and DNAmethyl-
ation (Heard and Disteche, 2006). Therefore, loss of resistance
may require the reversal of multiple layers of repressive features
added to genes undergoing silencing as cell differentiate.
Whether histone modifications are themselves functionally
implicated in the regulation of transcription is not well defined
(Henikoff and Shilatifard, 2011). Most functional tests are based
on the inactivation of histone-modifying complex. As a conse-
quence, it is difficult to disentangle the observed effect resulting
from loss of the histone mark to that resulting from loss of the
histone-modifying complex. An exception to this is the use of
mutant histone that cannot be methylated on a given lysine res-
idue (Herz et al., 2014). Drosophila expressing such histone
mutant, H3K27M, exhibits a phenotype that mimics the loss of
PRC2, directly implicating methylation of H3K27 in the observed
effect. A more conflicting picture emerges from the use of cells
engineered to have a PRC1 devoid of H2A ubiquitylation activity.
Some reports suggest that H2Aub is not required for the repres-
sion of transcription, whereas others found that it is (Endoh et al.,
2012; Illingworth et al., 2015; Pengelly et al., 2015). We observe
that three independent ways of globally interfering with
H2AK119ub1 as well as targeted removal of this histone modifi-
cation are able to reduce resistance to direct transcriptional re-
programming. This indicates that H2AK119ub1 itself contributes
to the observed resistance. In mouse ESCs, H2A deubiquity-
lases USP16 and USP21 are required for proper differentiation,882 Molecular Cell 65, 873–884, March 2, 2017suggesting that modulation of H2AK119ub1 genomic distribu-
tion is necessary for efficient change in cell fate (Jin et al.,
2016; Yang et al., 2014). It is, therefore, possible that overexpres-
sion of a H2A deubiquitinase in cultured cells could also improve
the efficiency of cell fate conversion in induced pluripotency.
To improve gene reactivation for efficient reprogramming, inter-
ference with multiple repressive pathways might be required.
However, we also observe that a combination of chromatin mod-
ifiers quite often has an adverse effect on resistance removal.
Indeed, it appears that some of the marks targeted can have
repressive functions on some resistant geneswhile being required
for proper reactivation of others. In that regard, refined strategies
involving the targeting of epigenetic modifiers to resistant genes
according to their sensitivity shouldprovideabetter transcriptional
reprogramming outcome (Zalatan et al., 2015). To achieve this,
further investigations are needed to delineate precisely which
part of the genome requires modification in order to relieve resis-
tance. In particular it would be important to more generally test
whether histone modifications impose resistance through large
domains or through localized deposition, as previous studies
have correlated the resistant state to the presenceofmodified his-
tones on large stretches of the genome (Matoba et al., 2014; Wen
etal., 2009). Lastly itwouldbe important tocompare the resistance
to transcriptional reprogramming in donor cells from different de-
grees of differentiation in order to establish whether the mecha-
nisms stabilizing cell identity change as cells differentiate.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
Mouse fibroblasts (p53/; p53/ Dnmt1N; and Ring1A/;Ring1Bfl/fl;Rosa26::CreERT2;SV40) were cultivated in Dulbecco’s
Modified Eagle Medium (DMEM), 5% Fetal Calf serum on gelatin coated dish. C57BL/6 ES cells were cultured without feeders on
gelatin coated dish in the presence of 1000U/ml leukemia inhibitory factor (LIF, CHEMICON ESG 1107) in Glasgow modification
of Eagles medium (GMEM BH-21, GIBCO 21710-025) containing 15% fetal calf serum (GIBCO 10439-024) supplemented with
1 mM MEK inhibitor PD0325901 (TOCRIS 4192), 3 mM GSK3 inhibitor CH99021 (Medchemexpress Europe, CHIR-99021), 0.1mM
non-essential amino acid (GIBCO 11140-035), 10mM sodium pyruvate (GIBCO 11360-039), and 0.1mM betamercaptoethanol
(GIBCO 31350-010). For nuclear transfer to mouse egg, ES cell CK35, were derived from 129Sv/Pas blastocysts (generous gift
from Pasteur Institute Mouse Functional Genetics Unit). Cells were cultured according to standard conditions in flasks, on gelatin,
in DMEM (GIBCO 31966-021) supplemented with 15% fetal calf serum (FISHER 10117272) and LIF (1000 U/ml, Cell Guidance:
GFM200).
Xenopus laevis laevis husbandry
Mature Xenopus laevismales and females were obtained from Nasco (901 Janesville Avenue, PO Box 901, Fort Atkinson, WI 53538-
0901; https://www.enasco.com/xenopus). Our work with Xenopus laevis is covered under the Home Office Project License PPL 70/
8591 and frog husbandry and all experiments were performed according to the relevant regulatory standards. Animals were kept in a
Marine Biotech recirculating system at a density of one adult/3l, with 10%water change per day. Water was sequentially filtered with
mechanical pad sump filter, nitrifying bacteria filter, mechanical canister filter, carbon filter, and UV sterilized. Water quality param-
eters were as follow: conductivity 1500us; temperature 17-22C; PH 6-8. Photoperiod was set to 12h ON/12h OFF. Frogs are fed
twice per weekwith Royal Horizon 4.5mmpellets (skretting, https://www.skrettingfishfeeds.co.uk/). Unconsumed foodwas removed
10 min after the start of feeding.
Mus musculus husbandry
Mus musculus (strains C57CBA; males and females) were obtained from Janvier Labs (Route des Cheˆnes Secs 53940 Le Genest-
Saint-Isle France; https://www.janvier-labs.com) and housed at the UE IERP rodent resource center from INRA in Jouy en Josas
(Unite Experimentale d’Infectiologie Experimentale des Rongeurs et Poissons). Animal care and handling at INRA is carried out ac-
cording to European regulations on animal welfare. N. Beaujean has the authorization toworkwith laboratory animals from the French
veterinary regulatory services (N78–95) and the present work on mouse has been approved by the ethics committee (no. 12/123;
Comethea Jouy-en-Josas/AgroParisTech). Animals are housed in groups of maximum 2-5 mice in cages enriched with tissues.
Water and standard pellet food are provided ad libitum. All mice are monitored daily for daily discomfort. Animals displaying overt
signs of discomfort (lack of activity or feeding behavior) are euthanized immediately by cervical dislocation.
METHOD DETAILS
Cytoplasmic injection and nuclear transplantation to Xenopus oocyte
This section was adapted from (Jullien, 2015).
Oocytes preparation
Ovaries are removed from a female Xenopus laevis terminally anesthetised by subcutaneous injection of 400ml ofMS222 (Ethyl 3-ami-
nobenzoate methanesulfonate, 0.6g/ml in H20) into the dorsal lymph sac. The ovaries are then placed in a petri dish containing 1X
MBS (MBS (Barth-HEPES Saline) 10X stock: 88mM NaCl, 1mM KCl, 2,4mM NaHCO3, 0.82mM MgSO4.7H2O, 0.33mM Ca(NO3)
2.4H2O, 0.41mMCacl2.6H2O, 10mMHEPES. Add3mL of 10NNaOH to obtain a pH of 7.4 to 7.6), and separated into small clumps
(containing roughly 50-100 oocytes) using forceps. Three to five ml of such clumps are transferred to a 50 mL falcon tube that is then
filled to 12.5 mL with 1X MBS. 6.5 units of liberase are then added to the solution and the oocytes are incubated 2h20 min at room
temperature (22C) with gentle agitation on a rocker (Liberase is prepared by resuspending 100 mg of lyophilized enzymes (Liberase
TMResearch / Roche 05 401 127 001) with 10mL sterile H2O (giving a final concentration of 26 U/ml). Let the solution stand for 30min
on ice to rehydrate. Gently swirl the vial every fewminutes to ensure that the enzyme is completely dissolved. Store aliquots of 250 mL
(6.5U) at -80C). Defolliculated oocytes are thenwashed 4 times in 50mL of 1XMBS and transferred to a Petri dish. Individual oocytes
are thenmanually sorted under a standard dissectingmicroscope using a Pasteur pipette and stored over night at 16-18C in 1XMBS
supplemented with penicillin streptomycin (P/S) at a final concentration of 10 mg/ml.
mRNA/gRNAs /BrUTP injection to oocyte’s cytoplasm
The oocytes are injected, in the cytoplasm, either one day prior (mRNAs) or two hours after (BrUTP, gRNAs) nuclear transfer. Using a
Drummond injector (Drummond Nanoject, Drummond Scientific Company, USA), the required amount of mRNAs or gRNAs (9nl at
1mg/ml), or BrUTP (Sigma: B7166, 4.6nl at 100mM), is injected in the cytoplasm from the vegetal pole of the recipient oocyte. Injected
oocytes are cultured in 1X MBS, P/S, 0.2%BSA at 18C.Molecular Cell 65, 873–884.e1–e8, March 2, 2017 e3
Donor cell preparation
Adherent cells such as mouse embryonic fibroblasts (MEF) or embryonic stem cells (ES) are collected by trypsinization according to
standard tissue culture procedure. Trypsin treatment is stopped by addition of cell culture medium supplemented with serum. The
cells are then washed twice in 1X PBS (137 mM NaCl; 2.7 mM KCl; 10 mMNa2HPO4; 2 mM KH2PO4; pH adjusted to 7.4 with HCl) by
centrifugation for 3 min at 500 g. Prior to proceeding to permeabilization, single cells are collected by filtering the cell suspension
through a 50 mm filters (Celltrics Partec 04-0042-2317). Cells are then counted on a hemacytometer and diluted to 1 million cells
per ml. One million cells (in one ml of 1X PBS) are transferred to an eppendorf tube and centrifugated 2min at 2000 g at RT. The
cell pellet is then resuspended in 1ml of SuNaSP (250mM Sucrose, 75mM NaCl, 0.5mM Spermidine, 0.15mM Spermine). The cells
are centrifugated again and resuspended in 200 mL of SuNaSP. 25 mL of Streptolysin O (SLO, 500 units) is then added to the suspen-
sion and the cells are incubated 5 min at 37C in a water bath (25000 units of Streptolysin O are resuspended in 1.25 mL PBS 0.01%
BSA. 62.5 mL of dTT 100mM is then added to the solution and incubated 2 hr at 37C. Aliquots of 25 mL are stored at -80C). After
incubation cells are placed on ice while the efficiency of permeabilization is checked. For that purpose 2 mL of the permeabilized cell
suspension is mixed with 8 mL of 0.4% trypan blue solution (0.4 gr trypan blue diluted in 100 mL of PBS 1X). Cells in trypan blue are
visualized on a hematocytometer. Permeabilization is successful when more than 90% of the cells show a nucleus stained blue and
blebs are apparent on the cell plasmamembrane. When permeabilization is confirmed to be satisfactory by the trypan blue test, SLO
is inactivated by adding 1 mL of SuNaSP 3%BSA to the 225 mL of permeabilized cells. Following SLO inactivation, cells are centri-
fugated 2min at 2000 g at RT. The permeabilized cells pellet is then resuspended in 55 mL of SuNaSP-BSA to give a final concentration
of 250 nuclei/13.8nl of solution. The permeabilized cells (‘‘nuclei’’) are then used for transplantation without further manipulation.
Transplantation procedure
Transcriptional reprogramming happens only when the nuclei are transplanted into the recipient oocyte own nucleus, the germinal
vesicle (GV). Theprotocol belowexplains how to transplant thenuclei and subsequently check for successfulGV targeting. First prepare
the injection needle: glass capillaries (7’’ Drummond #3-000-203-G/XL glass capillaries) are pulled in a Flaming/Brown micropipette
puller (Sutter instrument model P87 or p-7) using the following parameters: heat: set at the temperature established by a ramp test,
pull: 100, velocity: 100, time: 10. The needle tip then needs to be cut to give a relatively large opening (50 mm) to be able to suck
the donor nuclei suspension into the needle This can be done simply by using a dissecting scissor positioned at a 120 degree angle
to the needle. This will give a sharp enough needle tip that will penetrate the oocyte without damaging it. It then is helpful to mark the
needle with a marker pen at a distance of about 300 mm from the tip.The needle prepared in this way is filled with about 500 nL of
the nuclei suspension containing 5pg/13.8nl of a PCS2+-membrane GFP plasmid. To inject the nuclei, the oocyte is positioned toward
the needle with forceps. The needle has to contact themiddle of the pigmented (animal) pole of the oocyte and be orientated parallel to
the animal/vegetal pole axis. Once positioned, the needle is inserted in the oocyte at a depth of about 250 mm (using the penmark as a
reference) and the nuclei can then be injected (13.8nl containing 250 nuclei and 5pg of membrane GFP plasmid). GV targeting success
rate has to be checked for each injection needle used since slight differences in the size of the oocyte and the sharpness of the needle
affect the injection depth required. This is done by isolating theGV from the oocyte inMBS 1X and verifying the presence of nuclei in the
GV. If the nuclei are not transplanted to theGV, the targeting test is repeated varying the injection depth, using themarker pen reference
asaguide. Thenuclei suspension is kepton iceand theneedle is refilledwithnuclei from thestocksolutionevery20-30oocytes injected.
It is important to note that very often the nuclei suspension, when sucked into the needle, does not remain homogeneous. Indeed the
nuclei tend tobecomemoreconcentrated at the oil/nuclei solution interface. For that reason it is crucial to refill the needle frequently and
to then immediately transplant the nuclei to oocyte. This operating mode ensures that the quantity of nuclei delivered to the GV is con-
stant. After transplantation, theoocytesarecultured in 1XMBSsupplementedwith antibiotics (penicillin/streptomycin, gentamycin) and
0.2% BSA. The oocytes are kept at temperature of 18C and the culture medium is replaced every day. 24 hr after nuclear transplan-
tation, oocytes with successful GV targeting are sorted based on the presence of GFP fluorescence at the oocyte plasma membrane
(The membrane GFP RNA is produced only if the membrane GFP plasmid, and co-injected nuclei, are delivered to the oocyte GV).
Transcriptional reprogramming is typically assessed between 0 and 3 days after transplantation from GFP positive oocytes.
Analysis of transplanted Xenopus oocytes
Gene expression from transplanted nuclei
RNAs extraction. Pool of 8 oocytes are collected in eppendorf tubes and can be stored at -80C or directly processed for mRNA
extraction. For each experimental condition, 2 samples of 8 oocytes are processed. RNAs are extracted using RNAeasy mini kit (-
QIAGEN 74106), according to the manufacturer instruction, with ON-column DNase treatment and a 50 mL final elution volume
RNA immunoprecipitation
Beads saturation. Anti BrdU-agarose beads (Santa Cruz Biotechnology SC 32323, 25 mL /IP) are washed twice by adding buffer I
(0.5X SSPE (0.5mM EDTA and 74.5mMNaCl in 5mM phosphate buffer (pH 7.4) with 0.05% Tween20 and 0.1% polyvinylpyrrolidone
[PVP, SIGMA P5288])and spinning 2’ at 2rcf. Beads are then blocked overnight on a rotating wheel at 4C (up to 400 mL beads in 900
Buffer I supplemented with 100 mL of 10mg/ml RNase free BSA).
RNA immunoprecipitation
For each IP, 80 mL of RNA (40 mL from each samples) are added to 25 mL of saturated beads in 500 mL 0.5X SSPEwith 0.05% tween 20
and 6.25 mL of RNase inhibitor (Superase, Ambion AM2696) and placed on a rotating wheel for 4h at 4 degree. 20 mL of RNAs is kept
as an input fraction for RT-qPCR analysis.e4 Molecular Cell 65, 873–884.e1–e8, March 2, 2017
Beads washes
Washes are with 600 mL of buffer for 10 min on rotating wheel at 4C. Between washes samples are spun 2’ at 2rcf. First wash is with
low salt buffer (0.2X SSPE with 0.05% Tween20), followed by two washes with high salt buffer (0.5X SSPEwith0.05%Tween20 and
150mMNaCl). The last wash is with TET (10mMTris, 1mMEDTA, pH 8, and 0.05% Tween20. After the last wash, aspirate most of the
liquid so that the beads are dry.
Elution
RNAs are eluted by adding 100 mL elution buffer (300mMNaCl, 5mMTris, pH 7.5, 1mMEDTA, 0.1% SDS, 20mMdithiothreitol) to the
beads and incubate 5’ at RT. The beads are then centrifuged 2’ at 2rcf, and the supernatant containing the elutedRNAs collected. The
procedure is repeated four times to collect a total of 400ul of eluted RNAs Eluted RNA are phenol/chloroform (1:1Mix PH8) extracted,
and then precipitated by adding 1ml EtOH 100%,40 mL Na acetate 3M, 1 mg of glycogen and incubating 20min on dry ice. RNAs are
then pelleted by centrifugation 20min at 12000 rcf. Supernatant is discarded and the pellet is then washed with EtOH 70%, centri-
fuged 5min at 12000 rcf. The supernatant is removed, the pellets is dried for 5min at RT, and then resuspended in 12 mL H20.
RT-qPCR
Annealing of oligodT primers to the RNAs is performed by incubating at 65C for 5min 12 mL of RNA mixed with 0.5 mL of 100 mM
oligodT(15) and 0.5 mL of 10mM dNTPs followed by an incubation 5min on ice. cDNAs synthesis was performed by adding 4 mL
of 5X second strand buffer, 1 mL 0.1M dTT, 1 mL H2O, 0.5 mL RNase inhibitor, and 0.5 mL superscriptIII reverse transcriptase
(InVitrogen, 18080093) to the RNA solution and incubating at 50C for one hour. The reverse transcription is stopped by adding
80 mL of H2O to the reaction and incubating 10 min at 70
C. For qPCR, 5 mL of cDNAs were mixed with 12.5 mL SyberGreen (SIGMA,
S9194), 7.22 mL H2O, 0.14 mL each of Forward and Reverse primers (10 mM, see Table S8). The qPCR reaction was then performed on
StepOnePlus System (applied biosystem) using the standard detection mode option.
RNA-seq
To eliminate any trace of solvent after phenol extraction, RNA are further purified using ARCTURUS PicoPure RNA Isolation Kit
(Thermo Fisher, KIT0204) following the manufacturer instructions. 2 mL of purified RNAs (from a 10 mL volume of purified RNAs)
are then used to generate RNA-seq library using Ovation Single Cell RNA-Seq System (Nugen), following the two steps PCR option
of the manufacturer protocol.
WB analysis of histone modifications in transplanted nuclei
The GV containing transplanted nuclei are dissected out of the oocyte in GV isolation buffer (20mM Tris-HCl, pH7.5, 0.5mM
MgSO4, 140mM KCl). Within 1-2 min following dissection, the isolated GVs are transferred on ice to an eppendorf tube containing
non-denaturing wash buffer (150mM Tris-HC,l pH7.5, 50mM NaCl, 150mM KCl) supplemented with proteases inhibitors
(1000X stock solution: AEBSF, 104 mM; Aprotinin, 80 mM, Bestatin, 4 mM, E-64, 1.4 mM, Leupeptin, 2 mM, Pepstatin A,
1.5mM). The operation is repeated until about 30 GVs are collected (corresponding to about 7500 transplanted nuclei). The GV
containing the transplanted nuclei are then disrupted by brief vortexing (5 s), and centrifugated for 3 min at 12000 g. The super-
natant is discarded and the pellets containing the nuclei and GV membrane is washed twice in 1ml of non denaturing washing
buffer by vortexing 5 s and centrifugating for 3 min at 12000 g. The obtained pellets correspond mostly to transplanted chromatin
components since the washing process gets rid of most of the GV proteins that are not tightly bound to the transplanted nuclei. The
pellets can be frozen or directly processed for SDS-PAGE electrophoresis and WB analysis following a standard protocol. Quan-
titative immunoblotting was carried out on a LI-COR Odyssey CCD (charge-coupled device) scanner according to the manufac-
turer’s instructions (LI-COR Biosciences).
ChIP analysis
Chromatin preparation. Oocytes are washed in MBS 1X without BSA prior to fixation. Batch of oocytes (typically 56-84 oocytes per
experimental conditions) are transferred to a 15 mL falcon tube. Eight ml of 1X MBS containing 1% formaldehyde are added to the
oocytes and the samples are fixed for 10min at room temperature with gentle agitation. The fixation is stopped by the addition of 4ml
of MBS 1X with 300mM glycine. The oocytes are then washed three times in 10ml MBS 1X. Groups of 7 fixed oocytes are transferred
to eppendorf tubes in which MBS is replaced by 280 ml of homogenization buffer (50mM HEPES, pH7.8, 140mM NaCl, 1mM EDTA,
1% Triton X-100, 0.1% Na-deoxycholate) supplemented with 0.3% Sodium Dodecyl Sulfate (SDS), proteases inhibitors, and 1mM
DTT. Oocytes are thoroughly disrupted by pipetting up and down using a micropipette. Sonication is carried out in two cycles of
7min on a Sonicator equippedwith an ultrasonic bath (with 30 s on/off cycles, higher power). After sonication, the SDS in the sample
is diluted by adding 600 ml of homogenization buffer supplemented with proteases inhibitors and 1mM DTT. The sonicated chro-
matin is then centrifugated at 12000 g for 10 min at 4 degree. The supernatant (including the lipid layer) is then transferred to a new
tube. This chromatin can then be used in a standard ChIP protocol.
Chromatin immunoprecipitation
10% of the chromatin is taken as input and mixed with an equal volume of 23 Stop buffer (40 mM Tris-HCl at pH 8.0, 10 mM EDTA,
1% SDS) and 0.3 mg/mL proteinase K (final concentration). The inputs are incubated overnight at 65C. The rest of the sonicated so-
lution is mixed with antibody and incubated overnight at 4C on a rotating wheel. The antibodies used are: 1 mL of rabbit anti-HA
antibody (ab9110, Abcam) or rabbit anti H2AK119Ub1 antibody (cell signaling, 8240). After antibody reaction, 20 mL of dynabeads
protein G (Invitrogen) is added and is rotated for another 6 hr at 4C. The bead antibody conjugates are sequentially washed with
buffer I, buffer II (50 mM HEPES at pH 7.8, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM DTT,
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1 mM DTT, protease inhibitors), and TE containing 1 mM DTT and protease inhibitors for 30 min at 4C with rotation. After the last
wash, 150 mL of 1 3 Stop buffer with 0.3 mg/mL proteinase K is added to the beads, and cross-links are reversed by incubation
overnight at 65C. DNA from inputs and immunoprecipitates are then purified by phenol/extraction and ethanol precipitation and re-
suspended in a final volume of 50 mL of H2O.
ChIP qPCR and ChIP-seq
DNA is processed for qPCR analysis as described in the RT-qPCR section. Library for ChIP-seq were generated using TruSeq DNA
Sample Prep Kit (illumina; FC-121-2001) according to the manufacturer instructionsS8
Plasmid constructs and in vitro RNA synthesis
Human Kdm4D, mouse KDM6B (aa1025-1642), human USP21, and Xenopus laevis ring1B I49A were cloned using p-Entry cloning
system (Invitrogen, K2400-20 and 11791-020) into a pCS2+ destination plasmid with three C-terminal HA-tags and an N7-NLS-tag
(Cutler et al., 2000). mRNAs were synthesized in vitro using MEGAscript SP6 Kit (Ambion, AM1330M) following the manufacturer’s
instructions. Templates for in vitro synthesis of guide RNAs were produced by mixing 20 mL 5X HF buffer (M0530, New England bio-
labs), 10 mL dNTPs (2.5mM), 10 mL guide specific Forward primer (2 mM, see Table S8), 10 mL common guide Reverse primer (2 mM,
see Table S8), 1 mL Phusion High Fidelity DNA Polymerase (M0530, New England biolabs) and running a PCR reaction with the
following parameters: 30’’ initial denaturation at 98C, then 35 repeat of 15’’ denaturation at 98C, 30’’ annealing at 30C, and 15’’
elongation at 72C. The PCR reaction products were purified using QIAquick PCR Purification Kit (cat#28104, QIAGEN) according
to the manufacturer instructions and using a 50 mL elution volume. 8 mL of the purified PCR product (0.5 mg of DNA) was then
used in an in vitro RNA synthesis reaction with MEGAscript T7 Kit (Ambion, AM1334) following the manufacturer’s instructions
(20 mL total reaction volume).
Mouse nuclear transfer
Oocytes were prepared by superovulating eight-week old C57/CBAF1mice. Superovulation was induced by injecting pregnant mare
serum gonadotropin (PMSG, Intervet, 5 UI) and human chorionic gonadotropin (hCG, Intervet, 5 UI) at intervals of 48 hr. Oocytes were
collected from oviducts 14 hphCG (hours after injection of hCG) and washed in M2 medium containing 300 IU/ml hyaluronidase
(Sigma, H4272) to remove cumulus cells. Subsequently, they were incubated in M2 (Sigma, M7167) containing 5 mg/ml cytochalasin
B (SIGMA C6762) and placed in the same medium in a chamber on the stage of an inverted microscope (Olympus IX70) equipped
with micromanipulators (NarishigeMO-188). The chromatin spindle (visualized under differential interference contrast) was aspirated
into the pipette and removed. Donor nucleus, from ES cell synchronized in metaphase by 2 hr culture in medium containing
0.05 mg/ml of demecolcine (SIGMA D7385), were then isolated by gentle aspiration of the cell in and out of the injection pipette (inner
diameter 7–8 mm). Microinjected into the cytoplasm of the enucleated oocytes was then performed by Piezo-assisted technique. The
nuclear transfer embryos were activated by incubation for 3 hr in Ca2+-free medium containing 10 mM Sr2+. Embryos with visible
nuclei were considered as activated, were transferred into fresh M16 medium (Sigma, M7292) and cultured at 37C in a humidified
atmosphere containing 5% CO2. For microinjection embryos were placed in M2, in a chamber on the stage of a Nikon inverted
microscope equipped with Narishige micromanipulators and an Eppendorf microinjector. Embryos were microinjected in the cyto-
plasm with 1-2 pl of 1mg/ml USP21 mRNA, yielding an approximate dilution of 1/2000. Microinjections were performed at 4-5 hr post-
activation. Incubation was then carried out in M16 culture medium at 37C, 5% CO2 for further development.
Mouse embryos immunostaining
Embryos were fixed by placing them in 2% paraformaldehyde (PFA, EMS) in PBS for 10 min at room temperature and then permea-
bilized for 15min at room temperature using 0.5%Triton X-100 in PBS (Sigma-Aldrich). The embryoswere incubated in 2%BSA-PBS
for 1 hr (to block unspecific binding sites) and processed for in toto immunolabelling overnight at 4Cwith anti-ubiquityl-histone H2A
(Lys119) antibody (Cell Signaling, #8240S) diluted 1/200 in 2% BSA-PBS. After being washed two times 15 min with PBS, the
embryos were incubated for 1 hr at room temperature with an anti-rabbit AlexaCy3-conjugated secondary antibody (Jackson
ImmunoResearch Laboratories Inc., USA), diluted (1/200) in 2% BSA-PBS. DNA counterstaining was performed for 15 min at
37C using 5mg/ml DAPI (Invitrogen) in PBS. The embryos were washed using PBS and gently mounted on slides using a large
amount of Citifluor antifading agent (AF1 BioValley) to preserve the 3D structure of the nuclei.
Filtering and mapping of sequencing data
RNA-seq and ChIP-seq libraries were sequenced on an Illumina HiSeq 2000 instrument in single read mode at 40 or 50 base length.
Fastq files were filtered for low quality reads (< Q20) using sickle (Joshi and Fass, 2011) and low quality bases were trimmed from the
ends of the reads (< Q20). Adapters were removed using cutadapt 1.0 (Martin, 2011). For samples corresponding to mouse nuclei
transplanted to Xenopus oocytes, sequencing reads corresponding to mouse were obtained by mapping to a background genome
containingMousemm9 and Xenopus laevis 6.1 (Bowes et al., 2008). The sequencing readsweremapped to this background genome
using bwa 0.6.2 (Li and Durbin, 2009). Samtools 0.1.8 was used to generate sorted bam files from the output of bwa (Li et al., 2009).
Reads that mapped exclusively to a single genome were extracted with a further quality filter of mapping quality > 13 being applied
using bamtools 2.1.1 (Barnett et al., 2011). This resulted in BAM files representing the reads that exclusively map to each genome and
were used for further analysis. Single genome RNA-Seq samples weremapped with TopHat version 2.0.6 (Trapnell et al., 2009) alonge6 Molecular Cell 65, 873–884.e1–e8, March 2, 2017
with a junction file based on theMusmusculusUCSCmm9 genomewith RefSeq annotation. Reads were generated for each gene by
summing the number ofmapped reads overlapping its exons. Thesewere converted to RPKMs by normalizing by the total read count
for each sample and corresponding transcript lengths.
QUANTIFICATION AND STATISTICAL ANALYSIS
Description of biological replicates
RNA-seq
For Xenopus oocytes nuclear transfer experiments, two biological replicates (using different batch of oocytes and different donor cell
preparations) were used in each cases. RNA-seq library corresponding to one replicate originated from RNAs purified from 32 Xen-
opus oocytes each transplanted with250mouse nuclei. For nuclear transfer tomouse oocyte, three biological replicates were used
using different batch of oocytes and different donor cell preparations. In this case, RNA-seq library corresponding to one replicate
originated from RNAs purified from 7 to 10 two-cell stage cloned embryos. RT-qPCR: three to four biological replicates were used
(using different batch of oocytes and two different donor cell preparations). Within one replicate 3 samples with 8 NT-oocytes are
used for each experimental conditions. ChIP-Seq: two biological replicates (using different batch of oocytes and different donor
cell preparations) were used in each case. ChIP-seq library corresponding to one replicate originated from gDNAs purified from
80 Xenopus oocytes each transplanted with 250 mouse nuclei. ChIP-qPCR: Four biological replicates were used (using four
different batch of oocytes and two different donor cell preparations). Within one replicate 3 to 4 samples with 10 NT-oocytes are
used for each experimental conditions.
Gene Expression Analysis
Counts were generated by overlapping mapped reads with exonic positions defined by the UCSC RefSeq gtf file for mm9. RPKM
values were then generated through normalization to total read counts and transcript length. Where replicates were available for
both sample types in a pairwise comparison, transcripts were kept in the analysis if they had at least one count per million (CPM)
in either all samples of one type or all samples of the other type. Differentially expressed genes were identified in R (version 3.2.4)
with EdgeR (Robinson et al., 2010) by calculating the log2 fold change (logFC) and the false discovery rate (FDR). A threshold of
FDR < 0.05 was then used to select differentially expressed genes. Where replicates were not available on both sides of a compar-
ison, transcripts were kept if they had RPKM > 1 in all samples of either type. Differential expression was then defined by an absolute
value greater than one of the log fold change of the mean expression for each sample type in the pairwise comparison. For MA-plot,
the log2 FC in expression of transcripts between MEF-NT to ES-NT was plotted against the average donor cell gene expression
(log2(RPKM+1). Box-plots show distribution of mean gene expression levels of the different sets of transcripts. The middle line in
the box indicates the median, the box edges indicate the 25th/75th percentiles, the whiskers indicate the min and max. All plots
are produced using the boxplot command in R. Differences in gene expression levels between pairwise sets of genes were tested
using Mann-Whitney test (equivalent to Wilcoxon rank sum test). For RT-qPCR analysis the indicated genes were quantified using a
standard curve of mouse genomic DNA. The data was then visualized as mean value in a column bar graph with the standard error of
the mean as error bar. When indicated, significance was calculated using Student t test (+, P value < 0.05). Heatmaps: For our newly
generated expression data, the RPKMs used for heatmaps are averaged over the two replicates. For Figure 1C, a mean is taken for
each condition. Samples taken before NT and after NT are then internally normalized by the average value before NT and after NT,
respectively, and a log is taken. Finally, each sample is z-scored over all selected genes and the genes are ordered by fold change
from ES to MEF after NT. Expression data for cells before NT were taken from (Reddington et al., 2013) and (Bulut-Karslioglu et al.,
2014). In Figure 4F, expression values are z-scored and then split into groups using k-means clustering. In Figure 5E, the values indi-
cated are log2(1+RPKM) and they are reordered by unsupervised hierarchical clustering. Heatmaps were plotted using the heat-
map.2 function in R from the package gplots (Warnes et al., 2016) using z-scored expression values. For Figure 1C and Figure 4F,
no further clustering or reordering was performed by the package. For Figure 5E, rows were reorderded by the default unsupervised
hierarchical clustering (parameter Rowv = TRUE).
ChIP Analysis
For ChIP-Seq analysis, reads were counted in each 200bp bin for 10kb around the TSS of every genes. These counts were then
summed over all genes in each gene set of interest and normalized to the number of genes in the set, as well as the total read count
for the sample. For each IP the corresponding values for the paired input were subtracted. For ChIP-qPCR, the indicated genes were
quantified using a standard curve mouse genomic DNA. For normalization, the values of the IP were represented as percent of the
Input values. The data was then visualized as mean value in a column bar graph with the standard error of the mean as error bar.).
When indicated, significance was calculated using Mann-Whitney test (equivalent to Wilcoxon rank sum test; +, P value < 0.05)
GO and KEGG pathway enrichment
Analysis of enrichment on MEF resistant and ES resistant genes were carried out with DAVID using all mm9 genes as a back-
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Mouse embryo image quantitation
The embryos were observed using a Carl Zeiss (Germany) AxioObserver Zl fluorescence microscope equipped with the
ApoTome slider (MIMA2 Platform, INRA). Z series acquisition feature every 0.4 mm with a 63x Plan-Neofluar oil objective
(NA 1.3) and the same settings (acquisition time/laser power/gain/offset) for all samples. Raw images are available on the
Mendeley repository: http://dx.doi.org/10.17632/jzjspk58nv.1, http://dx.doi.org/10.17632/2nm2rvcx2y.1, http://dx.doi.org/10.17632/
ckzm2npz6h.1. The staining levels were estimated by quantifying fluorescence signals as follows, using Image-J software (National
Institute of Health, Bethesda, Maryland, USA): 1) the z-range was determined for each nucleus to evaluate its thickness and its radii
a/b were measured on the larger section; 2) the volume of each nucleus that is ellipsoidal was calculated with the mathematical formula
v = 4/3p*ab*(thickness/2); 3) a summing z-projection was realized; 3) the area of each nucleus was outlinedmanually and themean fluo-
rescence intensity as well as the nucleus area were measured; 4) the total fluorescence intensities for each nucleus were calculated ac-
cording to the following mathematical formula: total fluorescence = mean fluorescence * volume of the ellipsoid. For each experimental
replicate the average fluorescence levels of the injected group were normalized against the control group, which was set at 1 arbitrary
unit, and the replicates were then compared with a non-parametric test from Mann Whitney using the R stats package.
DATA AND SOFTWARE AVAILABILITY
The accession number for the ChIP-seq and RNA-seq datasets (40 Xenopus oocyte NT RNA-seq, 8 mouse egg NT RNA-seq,
and 4 ChiP-seq samples) reported in this paper is GEO: GSE87872 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=
ehgpswyqddmvzqt&acc=GSE87872).e8 Molecular Cell 65, 873–884.e1–e8, March 2, 2017
